agilon health inc. Statistics
Share Statistics
agilon health inc. has 412.02M shares outstanding. The number of shares has increased by 1.48% in one year.
Shares Outstanding | 412.02M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.05% |
Owned by Institutions (%) | n/a |
Shares Floating | 303.41M |
Failed to Deliver (FTD) Shares | 42.96K |
FTD / Avg. Volume | 0.95% |
Short Selling Information
The latest short interest is 36.22M, so 8.79% of the outstanding shares have been sold short.
Short Interest | 36.22M |
Short % of Shares Out | 8.79% |
Short % of Float | 11.94% |
Short Ratio (days to cover) | 8.1 |
Valuation Ratios
The PE ratio is -19.54 and the forward PE ratio is -6.68.
PE Ratio | -19.54 |
Forward PE | -6.68 |
PS Ratio | 1.19 |
Forward PS | 0.1 |
PB Ratio | 7.75 |
P/FCF Ratio | -27.44 |
PEG Ratio | n/a |
Enterprise Valuation
agilon health inc. has an Enterprise Value (EV) of 5.07B.
EV / Earnings | -19.31 |
EV / Sales | 1.17 |
EV / EBITDA | -30.24 |
EV / EBIT | -21.84 |
EV / FCF | -27.11 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.06.
Current Ratio | 1.51 |
Quick Ratio | 1.51 |
Debt / Equity | 0.06 |
Total Debt / Capitalization | 5.51 |
Cash Flow / Debt | -4.05 |
Interest Coverage | -34.87 |
Financial Efficiency
Return on equity (ROE) is -0.4% and return on capital (ROIC) is -32.67%.
Return on Equity (ROE) | -0.4% |
Return on Assets (ROA) | -0.15% |
Return on Capital (ROIC) | -32.67% |
Revenue Per Employee | 3.86M |
Profits Per Employee | -235.09K |
Employee Count | 1.12K |
Asset Turnover | 2.48 |
Inventory Turnover | 0 |
Taxes
Income Tax | 791.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -82.87% in the last 52 weeks. The beta is 0.6, so agilon health inc.'s price volatility has been higher than the market average.
Beta | 0.6 |
52-Week Price Change | -82.87% |
50-Day Moving Average | 2.48 |
200-Day Moving Average | 4.69 |
Relative Strength Index (RSI) | 50.15 |
Average Volume (20 Days) | 4.53M |
Income Statement
In the last 12 months, agilon health inc. had revenue of $4.32B and earned -$262.60M in profits. Earnings per share was $-0.64.
Revenue | 4.32B |
Gross Profit | 69.67M |
Operating Income | -232.13M |
Net Income | -262.60M |
EBITDA | -167.64M |
EBIT | -232.13M |
Earnings Per Share (EPS) | -0.64 |
Balance Sheet
The company has $107.57M in cash and $52.31M in debt, giving a net cash position of $55.26M.
Cash & Cash Equivalents | 107.57M |
Total Debt | 52.31M |
Net Cash | 55.26M |
Retained Earnings | -1.33B |
Total Assets | 2.09B |
Working Capital | 402.60M |
Cash Flow
In the last 12 months, operating cash flow was -$156.20M and capital expenditures -$30.82M, giving a free cash flow of -$187.01M.
Operating Cash Flow | -156.20M |
Capital Expenditures | -30.82M |
Free Cash Flow | -187.01M |
FCF Per Share | -0.46 |
Margins
Gross margin is 1.61%, with operating and profit margins of -5.38% and -6.08%.
Gross Margin | 1.61% |
Operating Margin | -5.38% |
Pretax Margin | -4.51% |
Profit Margin | -6.08% |
EBITDA Margin | -3.88% |
EBIT Margin | -5.38% |
FCF Margin | -4.33% |
Dividends & Yields
AGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -28.57% |
FCF Yield | -20.26% |
Analyst Forecast
The average price target for AGL is $3.5, which is 56.2% higher than the current price. The consensus rating is "Hold".
Price Target | $3.5 |
Price Target Difference | 56.2% |
Analyst Consensus | Hold |
Analyst Count | 17 |
Scores
Altman Z-Score | 1.77 |
Piotroski F-Score | 2 |